Systematic review of 132 IBD RCTs using 29 patient-reported outcome measures: definitions were highly heterogeneous, pooled placebo rates were 25.2% to 43.6%, and effect sizes were smaller than for primary endpoints. Few measures were extensively validated.
Meta-analysisn = 132 trials
Hanzel et al. Patient-Reported Outcomes in Clinical Trials of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis